126.35
전일 마감가:
$144.35
열려 있는:
$124.83
하루 거래량:
5.97M
Relative Volume:
2.04
시가총액:
$55.99B
수익:
$9.39B
순이익/손실:
$2.62B
주가수익비율:
21.74
EPS:
5.8121
순현금흐름:
$2.22B
1주 성능:
-13.14%
1개월 성능:
-13.74%
6개월 성능:
-19.78%
1년 성능:
-27.90%
조에티스 Stock (ZTS) Company Profile
명칭
Zoetis Inc
전화
973-822-7000
주소
10 SYLVAN WAY, PARSIPPANY, NJ
ZTS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
ZTS
Zoetis Inc
|
126.33 | 63.97B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.60 | 42.40B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.325 | 41.77B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.38 | 23.54B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
437.27 | 18.89B | 3.08B | 1.24B | 1.07B | 25.61 |
조에티스 Stock (ZTS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-17 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2025-06-18 | 다운그레이드 | Stifel | Buy → Hold |
| 2024-12-02 | 개시 | Leerink Partners | Outperform |
| 2024-07-25 | 개시 | BTIG Research | Buy |
| 2024-01-12 | 재확인 | Stifel | Buy |
| 2023-12-19 | 재개 | Jefferies | Buy |
| 2023-12-07 | 개시 | Exane BNP Paribas | Outperform |
| 2023-09-06 | 개시 | HSBC Securities | Buy |
| 2022-07-12 | 개시 | Piper Sandler | Overweight |
| 2021-11-18 | 개시 | Morgan Stanley | Overweight |
| 2021-08-05 | 재개 | Credit Suisse | Outperform |
| 2021-07-16 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2021-03-08 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2021-03-08 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2020-09-21 | 개시 | Atlantic Equities | Overweight |
| 2020-08-14 | 업그레이드 | Edward Jones | Hold → Buy |
| 2020-08-12 | 다운그레이드 | Gabelli & Co | Buy → Hold |
| 2020-05-27 | 개시 | Jefferies | Buy |
| 2020-01-10 | 개시 | Raymond James | Mkt Perform |
| 2019-09-09 | 개시 | Goldman | Buy |
| 2019-07-01 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2019-06-11 | 개시 | Barclays | Overweight |
| 2019-05-23 | 개시 | Guggenheim | Buy |
| 2019-05-03 | 다운그레이드 | Gabelli & Co | Buy → Hold |
| 2019-03-20 | 개시 | SunTrust | Hold |
| 2019-03-04 | 업그레이드 | Stifel | Hold → Buy |
| 2019-01-23 | 개시 | UBS | Neutral |
| 2018-10-15 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2018-08-22 | 다운그레이드 | Stifel | Buy → Hold |
| 2018-08-03 | 재확인 | Stifel | Buy |
| 2018-04-19 | 재확인 | Citigroup | Buy |
| 2018-03-19 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2018-02-16 | 재확인 | Stifel | Buy |
| 2018-01-04 | 업그레이드 | Citigroup | Neutral → Buy |
모두보기
조에티스 주식(ZTS)의 최신 뉴스
European Approval of Portela Could Be a Game Changer for Zoetis' (ZTS) Pet Health Pipeline - Yahoo Finance
Zoetis trims annual revenue forecast on muted demand for animal treatments, shares slide - MSN
Earnings call transcript: Zoetis Q3 2025 earnings beat EPS forecast, stock falls - Investing.com
Zoetis: A Buy Rating Amidst Slowed Growth and Promising Long-term Prospects - TipRanks
Zoetis (ZTS) Shares Experience Significant Decline - GuruFocus
Zoetis (ZTS) Shares Drop After Mixed Q3 Results and Revised Outl - GuruFocus
Zoetis down after guidance cut on macro trends - MSN
Zoetis stock hits 52-week low at 122.1 USD - Investing.com
Zoetis stock hits 52-week low at 122.1 USD By Investing.com - Investing.com Australia
Compared to Estimates, Zoetis (ZTS) Q3 Earnings: A Look at Key Metrics - Yahoo! Finance Australia
Zoetis stock down after guidance cut (ZTS:NYSE) - Seeking Alpha
Zoetis Inc. 2025 Q3ResultsEarnings Call Presentation (NYSE:ZTS) 2025-11-04 - Seeking Alpha
Zoetis (ZTS) Revises 2025 Revenue Forecast Amid Macro Trends - GuruFocus
Zoetis (ZTS) Records Q3 Revenue Slightly Below Projections, Achi - GuruFocus
Zoetis Stock Crumbles After Slashing 2025 Sales Outlook - MSN
Obermeyer Wealth Partners Purchases 127,101 Shares of Zoetis Inc. $ZTS - MarketBeat
Zoetis (ZTS) Surpasses Q3 Earnings Estimates - Yahoo! Finance Australia
Zoetis (ZTS) Q3 Earnings: EPS Surpasses Estimates, Revenue Falls Short - GuruFocus
(ZTS) Zoetis Expects Full Year 2025 Revenue Range $9.40B$9.48B, vs. FactSet Est of $9.51B - MarketScreener
Zoetis Q3 Adjusted Earnings, Revenue Rise; Annual Sales Outlook Revised -- Shares Down Pre-Bell - MarketScreener
(ZTS) Zoetis Expects Full-Year 2025 Adjusted EPS Range $6.30$6.40, vs. FactSet Est of $6.35 - MarketScreener
Zoetis trims annual revenue forecast on muted demand for animal treatments - MarketScreener
Earnings Flash (ZTS) Zoetis Inc. Reports Q3 Revenue $2.40B, vs. FactSet Est of $2.41B - MarketScreener
Zoetis Inc (ZTS) Q3 2025 Earnings: EPS of $1.63 Beats Estimates, Revenue at $2.4 Billion Slightly Misses Expectations - GuruFocus
Earnings Flash (ZTS) Zoetis Inc. Posts Q3 Adjusted EPS $1.70 per Share, vs. FactSet Est of $1.62 - MarketScreener
Zoetis (NYSE:ZTS) Reports Q3 In Line With Expectations But Stock Drops - The Globe and Mail
Zoetis falls after cutting annual revenue forecast - TradingView
Freestone Capital Holdings LLC Buys 3,506 Shares of Zoetis Inc. $ZTS - MarketBeat
Zoetis edges past Q3 revenue estimates, revises FY sales view - MarketScreener
Zoetis Inc. Q3 2025 Financial Results - TradingView
Zoetis: Q3 Earnings Snapshot - News-Times
Candlestick signals on Zoetis Inc. stock todayRate Cut & Real-Time Volume Analysis - newser.com
Zoetis Announces Third Quarter 2025 Results - The Joplin Globe
Can Zoetis Inc. stock hit record highs again2025 Technical Patterns & AI Driven Price Predictions - newser.com
Zoetis Inc. $ZTS Shares Sold by Bank of New York Mellon Corp - MarketBeat
7,694 Shares in Zoetis Inc. $ZTS Bought by Machina Capital S.A.S. - MarketBeat
South Dakota Investment Council Has $1.82 Million Stock Holdings in Zoetis Inc. $ZTS - MarketBeat
Bank of Montreal Can Has $121.85 Million Stock Position in Zoetis Inc. $ZTS - MarketBeat
Published on: 2025-11-04 04:25:23 - newser.com
TIAA Trust National Association Reduces Stock Position in Zoetis Inc. $ZTS - MarketBeat
GHP Investment Advisors Inc. Increases Stake in Zoetis Inc. $ZTS - MarketBeat
2,197 Shares in Zoetis Inc. $ZTS Acquired by Welch & Forbes LLC - MarketBeat
Can Zoetis Inc. Class stock deliver double digit returnsQuarterly Growth Report & Consistent Profit Trading Strategies - newser.com
Intraday pattern recognizer results for Zoetis Inc.July 2025 Sector Moves & Low Volatility Stock Recommendations - newser.com
Assetmark Inc. Purchases 2,876 Shares of Zoetis Inc. $ZTS - MarketBeat
Will Zoetis Inc. Class stock top growth indexes2025 Big Picture & Entry and Exit Point Strategies - newser.com
Zoetis President Rob Polzer to Retire - citybiz
Zoetis Announces Retirement of Rob Polzer at the End of 2025 and the Appointment of Kevin Esch as President of Research & Development for World Leader in Animal Health Beginning in 2026 - The Globe and Mail
Zoetis Stays On Track With Solid Earnings And Upbeat Outlook - Finimize
Zoetis announces retirement of Rob Polzer at the end of 2025 and the appointment of Kevin Esch as president of research & development for world leader in animal health beginning in 2026 - MarketScreener
Zoetis names Kevin Esch to succeed retiring R&D president Rob Polzer - Investing.com Canada
조에티스 (ZTS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):